$7.390
-0.128 (-1.73%)At close
Price Predictions
Open in app to unlock longer-horizon forecasts.
XGN Prediction & Forecast by Similar Chart Analysis
Alphio's XGN stock price prediction model matches the current Exagen Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $7.45 (+0.78%). The 1-week path is $7.41 (+0.31%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
Should I Buy Exagen Inc Stock?
Exagen Inc is a good buy right now, trading at $7.39 with a recent RSI of 54.76 indicating neutral momentum. The company reported a record revenue of $19.9 million in Q2 2026, which is a 16% year-over-year increase, and has raised its full-year revenue guidance to $72 million to $75 million. This growth trajectory, combined with a gross margin improvement to over 61%, suggests strong operational efficiency and market demand. However, the main risk is the negative net income, which was -$3.2 million in Q2 2026, indicating ongoing financial challenges that investors should consider.
XGN stock price ended at $7.39 on Friday, after losing -1.73%
Exagen Inc (XGN) last closed at $7.39, losing -1.73%. These facts feed the 1-day and 1-week XGN price prediction above.
Forecast Drivers
Exagen Inc (XGN) forecast drivers combine similar chart patterns, seasonality, and moving averages.
Similar patterns
Bullish
Seasonality
Bullish
SMA 20
Bullish
SMA 200
Bullish
Similar Chart Patterns
Stocks whose recent price path most closely matches XGN, ranked by similarity.
Seasonality analysis for XGN
Historically the probability of a positive August return for XGN is 98.41%. September offers the highest probability of a positive month at 100.00%, while March is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
10-year price projections for XGN
| Month | Min Price | Avg Price | Max Price | Potential ROI |
|---|---|---|---|---|
| Aug 2026 | $7.28 | $7.66 | $8.56 | +3.66% |
| Sep 2026 | $6.58 | $8.09 | $9.68 | +9.53% |
| Oct 2026 | $5.52 | $6.31 | $7.54 | -14.60% |
| Nov 2026 | $4.48 | $5.87 | $6.38 | -20.58% |
| Dec 2026 | $4.82 | $6.60 | $7.16 | -10.69% |
In 2026, Exagen Inc (XGN) is projected to range from $4.48 to $9.68.
Exagen Inc 2026 monthly forecast
In Aug 2026, Exagen Inc is projected to average $7.66, with a low of $7.28 and high of $8.56.
In Sep 2026, Exagen Inc is projected to average $8.09, with a low of $6.58 and high of $9.68.
In Oct 2026, Exagen Inc is projected to average $6.31, with a low of $5.52 and high of $7.54.
In Nov 2026, Exagen Inc is projected to average $5.87, with a low of $4.48 and high of $6.38.
In Dec 2026, Exagen Inc is projected to average $6.60, with a low of $4.82 and high of $7.16.
本页仅供研究参考，不构成投资建议。模型可能出错。过往表现不代表未来结果。